Market Analysis and Insights: Global Flavonoids Market

Favonoids are water soluble polyphenolic molecules containing 15 carbon atoms. Flavonoids belong to the polyphenol family. Flavanoids can be visualized as two benzene rings which are joined together with a short three carbon chain. One of the carbons of the short chain is always connected to a carbon of one of the benzene rings, either directly or through an oxygen bridge, thereby forming a third middle ring, which can be five or six-membered. The flavonoids consist of 6 major subgroups: chalcone, flavone, flavonol, flavanone, anthocyanins and isoflavonoids.

Due to the COVID-19 pandemic, the global Flavonoids market size is estimated to be worth US$ 195 million in 2022 and is forecast to a readjusted size of US$ 250.5 million by 2029 with a CAGR of 3.6% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Hesperidin accounting for % of the Flavonoids global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Pharmaceutical segment is altered to an % CAGR throughout this forecast period.

Global Flavonoids key players include SANREN Bio-Technology, Chengdu Shuxi Pharmaceutical, Chengdu Okay, Hunan Kang Biotech, Hunan Yuantong Pharmaceutical, etc. Global top five manufacturers hold a share nearly 40%.

Europe is the largest market, with a share over 35%, followed by China, and North America, both have a share about 50 percent.

In terms of product, Hesperidin is the largest segment, with a share about 80%. And in terms of application, the largest application is Pharmaceutical, followed by Food and Beverages, Dietary Supplements, Feed Additives, etc.

Global Flavonoids Scope and Market Size

The global Flavonoids market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Flavonoids market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.


Segment by Type


Hesperidin

Daidzein

Catechin

Genistein

Others


Segment by Application


Pharmaceutical

Food and Beverages

Dietary Supplements

Feed Additives

Others

By Region

United States

Europe

China

Japan

Southeast Asia

India

Other Regions


By Company


Zhejiang Conler Pharmaceutical

Chengdu Okay

Sichuan Deebio Pharmaceutical

Hunan Kang Biotech

Sichuan Xieli Pharmaceutical

Shaanxi Huifeng Pharmaceutical

SANREN Bio-Technology

Chengdu Shuxi Pharmaceutical

Hunan Yuantong Pharmaceutical

Chengdu Yazhong Bio-pharmaceutical

Chengdu Runde Pharmaceutical

Quzhou Tiansheng Plant Extract

Chengdu Hawk Bio-Engineering

Chongqing Zhuliu Bioengineering

Hunan Kingti Bio-Tech

ADM

Frutarom Health

Shaanxi Huike

Xi'an Desheng yuan

Jiangxi Shun Tiancheng

Taiyo Green Power

DSM

TEAREVO

Hunan Sunfull Bio-tech

Infré

Hunan Nutramax

Guangdong Yilong Industry Group

Hangzhou Qinyuan Natural Plant High-tech

Shanghai Novanat Bioresources

Chengdu Wagott Bio-Tech